openPR Logo
Press release

Cardiac Marker Market: Projected to Reach $12.47 Billion in 2025 with a CAGR of 10.8% and $20.35 Billion in 2029 with a CAGR of 13.0% Driven by Increasing Cardiovascular Diseases and Technological Advancements

01-23-2025 02:10 PM CET | Health & Medicine

Press release from: The Business Research Company

Cardiac Marker Market Outlook

Cardiac Marker Market Outlook

Get an in-depth analysis of the cardiac marker market, looking at projected size, key players, trends, and segments.

What Is The Projected Market Size Of The Global Cardiac Marker Market And Its Growth Rate?
• The cardiac marker market size was $11.26 billion in 2024 and is expected to grow to $12.47 billion in 2025, at a CAGR of 10.8%.
• This historic period growth can be attributed to factors such as increased incidence of cardiovascular diseases, aging population and cardiovascular risk, integration of biomarkers in clinical practice, and stringent regulatory standards and guidelines.
• The market size is projected to further rise to $20.35 billion in 2029, at a CAGR of 13.0%.
• The forecast period growth can be attributed to factors like rising burden of lifestyle-related diseases, advancements in remote monitoring and telemedicine, adoption of personalized medicine and precision diagnostics, increased point-of-care testing adoption.

What Is Driving The Growth In The Cardiac Marker Market?
The growth of the cardiac marker market going forward is largely driven by the rising prevalence of cardiac diseases. Cardiac diseases affect the structure or operation of the heart and result in a range of medical problems. Cardiac markers are generally used to diagnose and monitor numerous cardiac conditions, such as heart attacks, angina, heart failure, and other cardiovascular diseases. The demand for these diagnostic tests has seen a marked increase. For example, according to the British Heart Foundation, there were 30,000 more deaths from coronary heart disease from the start of the pandemic to August 2022 in England and a record 346,000 persons were on a cardiac waiting list by the end of August 2022. The rising prevalence of cardiac diseases, therefore, is fueling the growth of the cardiac marker market.

Request A Free Sample Copy:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10053&type=smp

Who Are the Key Players Driving Cardiac Marker Market Growth?
• Abbott Laboratories Inc.
• Siemens AG
• Danaher Corporation
• BioMérieux SA
• F. Hoffmann-La Roche AG
• Beckman Coulter Inc.
• Bio-Rad Laboratories Inc.
• Thermo Fisher Scientific Inc.
• Guangzhou Wondifo Biotech Co. Ltd.
• Creative Diagnostics
• PerkinElmer Inc.
• Tosoh Corporation
• Quidel Corporation
• Randox Laboratories Ltd.
• Getinge Group
• LSI Medience Corporation
• Ortho Clinical Diagnostics
• DiaSorin
• 3M Company
• Atom Medical Corporation
• Bionet America Inc.
• Bistos Inc.
• Clinical Innovations LLC
• Abcam plc
• General Electric Company

What Are The Key Trends In The Cardiac Marker Market?
Key trends in the forecast period include:
• Biomarker discovery and validation
• Personalized medicine approaches
• Technological advancements in assay platforms
• Integration of high-sensitivity troponin tests
• Increase in cardiovascular disease prevalence

What Are The Segments Of The Global Cardiac Marker Market?
• The market is segmented by biomarker into troponin, creatine kinase-MB (CK-MB), B-type natriuretic peptide (BNP), myoglobin, other biomarkers.
• The product segment includes reagent, instrument, chemiluminescence, immunofluorescence, immunochromatography, and ELISA.
• By indication, it is segmented into myocardial infarction, congestive heart failure, acute coronary syndrome, and other indications.
• The end users are laboratory testing facilities, hospital labs, reference labs, contract testing labs, point-of-care testing facilities, and academic institutions.

Which Region Leads The Cardiac Marker Market?
North America was the largest region in the cardiac marker market in 2024. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Pre-book the Report for Swift Delivery:
https://www.thebusinessresearchcompany.com/report/cardiac-marker-global-market-report

What Is Covered In The Cardiac Marker Market Global Market Report?
- Market Size Analysis: Analyze the Cardiac Marker Market size by key regions, countries, product types, and applications.

- Market Segmentation Analysis: Identify various subsegments within the Cardiac Marker Market for effective categorization.

- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.

- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.

- Market Contribution: Evaluate contributions of different segments to the overall Cardiac Marker Market growth.

- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.

- Industry Challenges: Analyze challenges and risks affecting the Cardiac Marker Market.

- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Request Customization for This Report:
https://www.thebusinessresearchcompany.com/Customise?id=10053&type=smp

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cardiac Marker Market: Projected to Reach $12.47 Billion in 2025 with a CAGR of 10.8% and $20.35 Billion in 2029 with a CAGR of 13.0% Driven by Increasing Cardiovascular Diseases and Technological Advancements here

News-ID: 3830254 • Views:

More Releases from The Business Research Company

Segment Evaluation and Major Growth Areas in the Personalized Testing and Supplements Market
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future. Market Valuation and Expansion Forecast for Personalized Testing
Top Players and Market Competition in the Skin Microbiome Industry
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry. Projected Expansion in the Skin
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market Landscape
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory. Steady Growth Expected in Upadacitinib Market Size Through 2029 The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Market
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field. Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics

All 5 Releases


More Releases for Cardiac

Cardiac Resynchronization Therapy: Driving Innovation and Transforming Global Ca …
London, UK - August 2025 | Strategic Revenue Insights Inc. The global cardiac resynchronization therapy (CRT) market is emerging as one of the most crucial sectors in cardiovascular healthcare, offering life-saving solutions for patients with heart failure and conduction abnormalities. CRT devices, including pacemakers and defibrillators, are designed to restore synchronized heart contractions, significantly improving patient survival rates and quality of life. With rising cardiovascular disease prevalence worldwide, CRT has
Mobile Cardiac Telemetry Systems Market Redefining Remote Cardiac Monitoring
"In recent years, the global Mobile Cardiac Telemetry Systems Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Mobile Cardiac Telemetry Systems Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot
Ambulatory Cardiac Monitoring Devices Market: Revolutionizing Cardiac Care
In the rapidly evolving landscape of healthcare, the Ambulatory Cardiac Monitoring Devices Market stands out as a beacon of innovation and progress. These devices, including ECG devices, Holter monitors, event monitors, implantable loop recorders, and mobile cardiac telemetry, have become indispensable tools for healthcare professionals in managing and diagnosing cardiac conditions. As heart-related issues continue to afflict millions globally, the demand for advanced cardiac monitoring solutions is on the rise. Request
Cardiac Monitoring & Cardiac Rhythm Management Devices Market - Precision Monito …
Newark, New Castle, USA: The "Cardiac Monitoring & Cardiac Rhythm Management Devices Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Cardiac Monitoring & Cardiac Rhythm Management Devices
Cardiac Monitoring & Cardiac Rhythm Management Device Market
According to a new market research report published by Global Market Estimates, the Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market is expected to grow at a CAGR of 3.88% during the forecast period. The increasing occurrence of dyslipidemia, hypertension, and rising demand for cardiac monitoring & cardiac rhythm management devices to save patients at a huge risk of cardiac arrest. Browse 145 Market Data Tables and 119 Figures spread
Global Cardiac Monitoring & Cardiac Rhythm Management Market Insights, Forecast
Cardiac monitoring (CM) devices help in continuous examination of a patient’s cardiac activity. Cardiac rhythm management (CRM) devices maintain normal cardiac rhythm in patients suffering from rate and rhythm disorders of the heart. These devices play a crucial role in the treatment of serious cardiac disorders, including heart failure, atrial fibrillation, atrial flutter, indications of recent heart attack, coronary ischemia, lack of oxygen supply to cardiac muscles, effects of drugs,